drugset / Trial / NCT00646880
A Study to Evaluate the Efficacy of Tolterodine Prolonged Release Compared With Propiverine for the Treatment of Korean Patients With Overactive Bladder as Assessed by Ambulatory Urodynamic Monitoring
RandomizedCrossoverDouble-blindTreatment
Summary
The purpose of this study is to compare the difference between tolterodine prolonged release (PR) and propiverine in efficacy as assessed by the AUM and to show that tolterodine PR is similar to propiverine with respect to micturition chart variables and safety profile.
Timeline
- Start
- 2003-03
- Primary completion
- —
- Completion
- 2003-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Propiverine | Small molecule | 20 mg | — |
| Comparator | Tolterodine | Small molecule | 4 mg | — |